About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of Action
NIRIDAZOL (ID 26887) exhibits a complex and multi‑pathway biochemical activity pattern that may involve modulation of enzyme‑regulated catalytic cascades, receptor‑mediated intracellular signalling, mitochondrial bioenergetics, redox‑state homeostasis, membrane‑potential stabilisation, and transcription‑factor regulatory networks. Structural properties suggest possible interactions with catalytic residues, allosteric binding pockets, regulatory scaffolding proteins, transmembrane receptors and intracellular signalling intermediates. These mechanisms allow NIRIDAZOL to influence phosphorylation–dephosphorylation cycles, second‑messenger systems (Ca²⁺, cAMP, IP₃, DAG), ROS buffering dynamics, ATP synthesis efficiency and the structural organisation of cytoskeletal components.
Depending on concentration and biological context, NIRIDAZOL may shift metabolic routing, alter calcium flux, affect vesicular transport, reshape transcriptomic output and modify mitochondrial respiratory‑chain performance, contributing to its broad experimental applicability.
Benefits and Advantages
This compound is frequently used in advanced biochemical, pharmacological and mechanistic research areas, including:
- Receptor–ligand interaction profiling and affinity‑mapping studies
- Enzyme‑kinetic characterisation and catalytic‑pathway modelling
- Mitochondrial‑function assays, ATP‑flux analysis and oxidative‑stress modelling
- Transcriptomics, proteomics, metabolomics and phosphoproteomics investigations
- Cytoskeletal‑dynamics studies involving actin/tubulin regulation and membrane‑mechanics research
- Apoptosis, autophagy, ferroptosis and necroptosis pathway explorations
- Structure–activity relationship (SAR) development and molecular‑performance optimisation
- Pharmacodynamic threshold modelling and dose–response curve definition
Side Effects and Risks
Laboratory‑observed or theoretically predicted risks include:
- Redox imbalance, ROS accumulation and oxidative‑stress sensitisation
- Mitochondrial overload or suppression of respiratory‑chain complexes
- Disruption of ion‑channel homeostasis (Na⁺/K⁺/Ca²⁺)
- Unintended receptor cross‑activation or inhibition
- Membrane‑integrity compromise and cytoskeletal destabilisation
- Dose‑dependent cytotoxicity, apoptosis or excessive autophagy
- Transcriptional pathway destabilisation or inflammatory activation (NF‑κB, JNK, MAPK)
Prolonged exposure or excessive dosing may trigger metabolic collapse, transcriptional rewiring or epigenetic instability. Use solely in controlled laboratory environments under strict biosafety protocols.
Datasheet
| Molecular Formula | C9H10N4O3S |
|---|---|
| Molecular Weight | 214.20 g/mol |
| CAS Number | 61-57-4 |
| Storage Condition | PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for … expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties …) that bears appropriate label. An inventory … should be kept, showing quantity of carcinogen & date it was acquired … Facilities for dispensing … should be contiguous to storage area. /Chemical Carcinogens/ |
| Solubility | Insoluble in most organic solvents; soluble in dimethylformamide |
| Purity | Purity information is available upon request (COA). |
| Synonym | Niridazole; 61-57-4; Nitrothiazole; Ambilhar; Nitrothiamidazol |
| IUPAC/Chemical Name | 1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one |
| InChl Key | RDXLYGJSWZYTFJ-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C6H6N4O3S/c11-5-7-1-2-9(5)6-8-3-4(14-6)10(12)13/h3H,1-2H2,(H,7,11) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
